DeepMed Research

Jiangsu Province Centers for Disease Control and Prevention

People's Republic of China

Country: People's Republic of China

Ownership: Private

Employees: -

Market Cap: -

Website: http://www.jstd.gov.cn/

Clinical Trials

Immunogenicity and Safety of Subunit Plague Vaccine

Phase 2

Completed

Conditions: Plague

Interventions: Biological: Plague vaccine

First Posted Date: 2015-11-04

Last Posted Date: 2015-11-04

Lead Sponsor: Jiangsu Province Centers for Disease Control and Prevention

Target Recruit Count: 240

Registration Number: NCT02596308

Locations: 🇨🇳
Jiangsu Provincial Center for Disease Control and Prevention, Nanjing, Jiangsu, China

A Clinical Trial to Evaluate the Recombinant Human Type5 Adenovirus Vector Based Ebola Virus Disease Vaccine

Phase 2

Completed

Conditions: Ebola Disease

Interventions: Biological: Placebo
Biological: Ebola Vaccine

First Posted Date: 2015-10-14

Last Posted Date: 2016-09-01

Lead Sponsor: Jiangsu Province Centers for Disease Control and Prevention

Target Recruit Count: 500

Registration Number: NCT02575456

Locations: 🇸🇱
Dr. Alie H Wurie, Freetown, Sierra Leone

A Booster Dose of Ad5-EBOV in Healthy Adults After Primary Immunization

Phase 1

Completed

Conditions: Ebola Virus Disease

Interventions: Biological: 4×10^10vp/1ml Ebola Zaire vaccine (Ad5-EBOV)
Biological: 1.6×10^11vp/2ml Ebola Zaire vaccine (Ad5-EBOV)
Biological: placebo

First Posted Date: 2015-08-27

Last Posted Date: 2015-10-14

Lead Sponsor: Jiangsu Province Centers for Disease Control and Prevention

Target Recruit Count: 110

Registration Number: NCT02533791

Locations: 🇨🇳
Phase 1 vaccine clinical trial center of Jiangsu Provincial Center for Disease Control and Prevention, Taizhou, Jiangsu, China

A Phase III Clinical Trial of a 13-valent Pneumococcal Conjugate Vaccine in Healthy Infants

Phase 3

Completed

Conditions: Pneumonia

Interventions: Biological: Prevnar 13
Biological: 13-valent pneumococcal conjugate vaccine

First Posted Date: 2015-07-13

Last Posted Date: 2020-05-13

Lead Sponsor: Jiangsu Province Centers for Disease Control and Prevention

Target Recruit Count: 1200

Registration Number: NCT02494999

Locations: 🇨🇳
Huaiyin District Center for Diseases Control and Prevention, Huai'an, Jiangsu, China
🇨🇳
Hongze District Center for Disease Control and Prevention, Huai'an, Jiangsu, China
🇨🇳
Lianshui County Center for Disease Control and Prevention, Huai'an, Jiangsu, China

and more 1 locations

A Phase 3 Clinical Trial for a Rabies Vaccine (Vero Cell) for Human Use in Healthy Chinese Subjects

Phase 3

Completed

Conditions: Rabies

Interventions: Biological: Jilin Maifeng
Biological: Changchun Werersai

First Posted Date: 2015-07-08

Last Posted Date: 2015-07-09

Lead Sponsor: Jiangsu Province Centers for Disease Control and Prevention

Target Recruit Count: 1200

Registration Number: NCT02491541

Locations: 🇨🇳
Xinyi Center for Disease Control and Prevention, Xuzhou, Jiangsu, China

Study of Adsorption Tetanus-diphtheria-acellular Pertussis (DTaP) Vaccine in Healthy 3 to 5 Months Infants

Phase 3

Completed

Conditions: Pertussis

Interventions: Biological: DTaP Vaccine A
Biological: DTaP Vaccine B

First Posted Date: 2015-06-23

Last Posted Date: 2015-06-23

Lead Sponsor: Jiangsu Province Centers for Disease Control and Prevention

Target Recruit Count: 1200

Registration Number: NCT02477995

Locations: 🇨🇳
Jiangsu Provincial Center for Diseases Control and Prevention, Nanjing, Jiangsu, China

A Clinical Trial for Inactivated Japanese Encephalitis Vaccine in Healthy Chinese Infants

Phase 3

Completed

Conditions: Encephalitis

Interventions: Biological: 0.5ml experimental vaccine on day 0,7 Vero cell-derived inactivated Japanese Encephalitis vaccine
Biological: 0.5ml experimental vaccine on day 0,28 Vero cell-derived inactivated Japanese Encephalitis vaccine
Biological: 0.5ml active comparator vaccine on day 0,7 inactivated freeze-dried Japanese Encephalitis vaccine(Vero cell)

First Posted Date: 2015-02-20

Last Posted Date: 2016-09-01

Lead Sponsor: Jiangsu Province Centers for Disease Control and Prevention

Target Recruit Count: 900

Registration Number: NCT02367664

Locations: 🇨🇳
Pizhou Center for Disease Control and Prevention, Xuzhou, Jiangsu, China

A Phase I Clinical Trial to Evaluate the Ebola Adenovirus Vector Vaccine (Ad5-EBOV) in Healthy Adults.

Phase 1

Completed

Conditions: Ebola Virus Disease

Interventions: Biological: placebo (one dose)
Biological: High dose Ebola Zaire vaccine (Ad5-EBOV)
Biological: Low dose Ebola Zaire vaccine (Ad5-EBOV)
Biological: placebo (two doses)

First Posted Date: 2014-12-25

Last Posted Date: 2015-08-28

Lead Sponsor: Jiangsu Province Centers for Disease Control and Prevention

Target Recruit Count: 120

Registration Number: NCT02326194

Locations: 🇨🇳
Phase 1 vaccine clinical trial center of Jiangsu Provincial Center for Disease Control and Prevention, Taizhou, Jiangsu, China

A Phase Ⅲ Clinical Trial With Oral Recombinant Helicobacter Pylori Vaccine in Chinese Children

Phase 3

Completed

Conditions: H. Pylori Infection

Interventions: Biological: H. pylori vaccine
Biological: placebo

First Posted Date: 2014-11-26

Last Posted Date: 2014-11-26

Lead Sponsor: Jiangsu Province Centers for Disease Control and Prevention

Target Recruit Count: 4464

Registration Number: NCT02302170

Locations: 🇨🇳
Jiangsu Provincial Center for Diseases Control and Prevention, Nanjing, Jiangsu, China

A Phase I Clinical Trial for Inactivated Quadrivalent Influenza Vaccine (Split Virion) in Healthy Adults in China

Phase 1

Completed

Conditions: Influenza

Interventions: Biological: inactivated quadrivalent influenza vaccine (split virion)

First Posted Date: 2014-10-20

Last Posted Date: 2015-10-14

Lead Sponsor: Jiangsu Province Centers for Disease Control and Prevention

Target Recruit Count: 110

Registration Number: NCT02269007

Locations: 🇨🇳
Guanyun County Center for Disease Control and Prevention, Liangyungang, Jiangsu, China

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy